Overview
Wen-shin Chang practices practicing medicine in Taitung, Taiwan.
Chang is highly rated in 9 conditions, according to our data. Their clinical expertise encompasses Pterygium, Triple-Negative Breast Cancer, Nijmegen Breakage Syndrome, and Atelosteogenesis Type 1.
They are actively involved in clinical research, co-authoring 271 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Wen-shin H. Chang
Is Wen-shin H. Chang a top-rated expert for Pterygium?
MediFind is an objective health platform that identifies experts based on real-world data. Wen-shin H. Chang is classified as an Distinguished expert for Pterygium, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Wen-shin H. Chang participate in research or clinical trials?
Yes. Wen-shin H. Chang has published 271 articles and abstracts on conditions like Pterygium. You can view a list of Wen-shin H. Chang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- PterygiumChang isDistinguished. Learn about Pterygium.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Atelosteogenesis Type 1Chang isAdvanced. Learn about Atelosteogenesis Type 1.
- Helicobacter Pylori Infection
- Nasopharyngeal Carcinoma
- Nijmegen Breakage Syndrome
- Renal Cell Carcinoma (RCC)
- Triple-Negative Breast Cancer
- Xeroderma PigmentosumChang isAdvanced. Learn about Xeroderma Pigmentosum.
- Experienced
- AsthmaChang isExperienced. Learn about Asthma.
- Bladder CancerChang isExperienced. Learn about Bladder Cancer.
- Breast CancerChang isExperienced. Learn about Breast Cancer.
- Colorectal CancerChang isExperienced. Learn about Colorectal Cancer.
- Embryonal Tumor with Multilayered Rosettes
- EndometriosisChang isExperienced. Learn about Endometriosis.
- Gliomatosis CerebriChang isExperienced. Learn about Gliomatosis Cerebri.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- HypertensionChang isExperienced. Learn about Hypertension.
- LeukemiaChang isExperienced. Learn about Leukemia.
- Liver CancerChang isExperienced. Learn about Liver Cancer.
- Lung CancerChang isExperienced. Learn about Lung Cancer.
- NeuroblastomaChang isExperienced. Learn about Neuroblastoma.
- Neurotoxicity SyndromesChang isExperienced. Learn about Neurotoxicity Syndromes.
- Prostate CancerChang isExperienced. Learn about Prostate Cancer.
- SilicosisChang isExperienced. Learn about Silicosis.
- Stomach CancerChang isExperienced. Learn about Stomach Cancer.
- Uterine FibroidsChang isExperienced. Learn about Uterine Fibroids.